CPC-211 small molecule that facilitates anaerobic metabolism data

CYPR (Carlsbad, Calif.) announced that a Phase I trial in 36 healthy volunteers demonstrated lowered plasma lactate, an indication of efficacy because lactate is the toxic metabolite present in all cerebral ischemic disorders. ...